验证数据展示
经过测试的应用
Positive IF-P detected in | human placenta tissue |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
CL488-66248 targets PD-L1/CD274 in IF-P applications and shows reactivity with human, mouse, pig, rat samples.
经测试应用 | IF-P Application Description |
经测试反应性 | human, mouse, pig, rat |
免疫原 | PD-L1/CD274 fusion protein Ag12443 种属同源性预测 |
宿主/亚型 | Mouse / IgG1 |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | CD274 molecule |
别名 | B7 H, B7 H1, B7 homolog 1, B7H1, CD274, CD274 molecule, PD L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, PDL1, PD-L1/CD274, Programmed death ligand 1 |
计算分子量 | 290 aa, 33 kDa |
观测分子量 | 50 kDa |
GenBank蛋白编号 | BC074984 |
基因名称 | PD-L1 |
Gene ID (NCBI) | 29126 |
RRID | AB_3672908 |
偶联类型 | CoraLite® Plus 488 Fluorescent Dye |
最大激发/发射波长 | 493 nm / 522 nm |
形式 | Liquid |
纯化方式 | Protein G purification |
UNIPROT ID | Q9NZQ7 |
储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Programmed cell death ligand 1 (PD-L1, CD274, or B7-H1), is the first member of B7 family to be discovered. B7 family molecules are type I transmembrane proteins belonging to the immunoglobulin superfamily. In concert with their CD28 family receptors, the B7s are key regulators of the adaptive immune response. PD-L1 is suggested as a negative regulator of T and B cell, and plays important role in mediating tolerance of lymphocytes to self-antigens. It is also involved in the costimulatory signal, essential for T-cell proliferation and production of IL10 and IFNG, in an IL2-dependent and a PD-1-independent manner.
实验方案
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 PD-L1/CD274 antibody CL488-66248 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |